Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **bacterial cell outer membrane** is a characteristic feature of Gram-negative bacteria, forming the outermost layer of the cell envelope and encapsulating the periplasmic space, which lies between it and the inner cytoplasmic membrane[1][2]. The outer membrane is an asymmetric bilayer composed of phospholipids (inner leaflet) and lipopolysaccharide (LPS; outer leaflet). LPS consists of lipid A (endotoxin), core oligosaccharide, and variable O-antigen. The membrane contains various proteins, including porins (channels for small molecule diffusion), substrate-specific transporters, lipoproteins, and efflux pumps[1][4][7]. Unlike typical biological membranes, many outer membrane proteins adopt anti-parallel beta-barrel structures. Biologically, the outer membrane provides a robust permeability barrier, protecting bacteria from antibiotics, toxins, and harsh environments, anchoring virulence factors, mediating interactions with hosts, and contributing to structural integrity and cell morphogenesis[3][5][7]. Clinical significance arises from its LPS component: lipid A is a potent activator of the immune system and can cause endotoxic shock, while the OM’s impermeability complicates antibiotic therapy and promotes multidrug resistance[1][5]. Although individual proteins and components of the bacterial outer membrane are direct drug targets, the **outer membrane itself is a cellular structure, not a canonical therapeutic target such as a receptor, enzyme, or transporter**. **Explanation:** - The term "Bacterial cell outer membrane" refers to a complex cell structure and not a single molecular target, protein, or canonical drug target class such as a receptor or enzyme[2]. - Its components (lipopolysaccharide, porins, efflux pumps) may be targets, but the entire structure is not conventionally listed as such in drug hunting or medical databases[1][4][5]. - Therefore, **is_target: false** and **is_incorrect: true** (too broad, not a molecular target in the sense typical to drug discovery; should be decomposed into its protein or lipid components for target lists).
Disruption of membrane integrity (polymyxins bind LPS, increase permeability, and cause cell death) - Chelation of divalent cations (EDTA destabilizes OM, sensitizing bacteria to other agents) - Passive diffusion/porin-mediated entry for some antibiotics
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell outer membrane.